Hidden hearing aid? new implant could restore speech without visible parts
NCT ID NCT06459765
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new type of cochlear implant that is completely hidden under the skin, with no external parts. Thirty adults with severe hearing loss received the implant to see if it improved their ability to understand speech. Participants took word and sentence tests, hearing checks, and quality-of-life surveys before and after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mi2000 totally implantable cochlear implant (device)
- What this could lead to
- If successful, this device could provide a fully hidden cochlear implant that improves speech understanding in quiet and noise, offering a more discreet and convenient option for people with severe hearing loss.
- What could go wrong
- This is a small, completed study with only 30 participants, so results may not apply to everyone. The device is new and may have unknown risks or technical issues, and long-term benefits are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Sep 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Minimum age of eighteen (18) years at time of enrolment * Bilateral sensorineural hearing loss with no or limited benefit from a hearing aid (\>70 dB HL PTA4) * Post-lingual onset of deafness * No or limited benefit from hearing aids for less than 10 years and an expected benefit from cochlear implantation * A maximum score of 50% on a word test in the language of the test centre in the ear to be implanted in the best aided condition * Fluency in the test language with excellent proficiency, as appropriate to perform speech testing * Functional auditory nerve * General health condition, psychological and emotional condition deemed compatible with the treatment and tests performed in this study * Pre-operative assessment according to the local professional standards * Candidate is highly motivated and has realistic expectations about the expected benefit of the implant and shall understand the importance of returning to the implant centre for regular speech processor programming, assessment sessions and training * Realistic expectations, as deemed appropriate by the implanting surgeon/implant board * Evidence of up-to-date vaccinations against meningitis, as per recommendations by the applicable national body * Signed and dated informed consent before the start of any study-specific procedure Exclusion Criteria: * Lack of compliance with any inclusion criterion * Previously having received an implant on the location chosen for placing the cochlear implant * Having received a hearing implant from another manufacturer than MED-EL on the contralateral ear * Pre-existing condition known to necessitate MRI scans after implantation of the Mi2000 TICI * Women being pregnant or nursing * Women of childbearing age not reporting to use effective contraception * The individual is known to be intolerant of the materials used in the implant or other required accessories including medical grade silicone, parylene C, titanium, platinum iridium, platinum, stainless chromate steel, thermoplastic elastomere (TPE-S), thermoplastic elastomere (SEBS), mixture of polycarbonate and acrylonitrile-butadiene-styrol polymer (PC/ABS), polyamide, liquid crystal polymer, silicone and polyurethane-coated silicone rubber) * Absence of cochlear development * The cause of deafness is non-functionality of the auditory nerve and/or the upper auditory pathway * Medical contra-indications to middle ear and/or inner ear surgery, and/or anaesthesia * External or middle ear infections are present * The tympanic membrane is perforated in the ear to be implanted * Anatomic abnormalities are present that would prevent appropriate placement of the stimulator housing in the bone of the skull, or prevent placement of the chosen electrode array into the cochlea (including ossification of the cochlea) * The psychological status of the individual is unstable * The individual has unrealistic expectations * Acute cholesteatoma * History of vestibular schwannoma * Unstable Meniere's disease * Auditory Neuropathy * Epilepsy not responding to treatment * Permanent inability and/or unwillingness to participation in post-operative care and rehabilitation * Known intellectual disability and/or psychological diseases * Participation in other pharmacological clinical trials within four weeks prior to enrolment * Anything that, in the opinion of the Investigator, would place the subject at increased risk; preclude the subject's full compliance with or completion of the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hearing loss, sensorineural are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AKH Wien
Vienna, 1090, Austria
-
CHU Liège
Liège, 4000, Belgium
-
LMU Munich
München, Bavaria, 81377, Germany
-
The Institute of Physiology and Pathology of Hearing
Nadarzyn, 05-830, Poland
-
UKW Würzburg
Würzburg, Bavaria, 97080, Germany
-
UZA Antwerpen
Antwerp, 2650, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a custom sound map unlock better hearing for cochlear implant users?
- Can a new bone conduction implant restore hearing for the long haul?
- Can eye movements reveal the hidden toll of hearing loss?
- Could a blood concentrate make cochlear implants work better?
- One-Time injection aims to restore hearing in children born deaf
- Open-Source hearing aid could make better hearing more accessible